FR2757059B1 - Nouvelle application therapeutique des derives du pyrrole - Google Patents

Nouvelle application therapeutique des derives du pyrrole

Info

Publication number
FR2757059B1
FR2757059B1 FR9615287A FR9615287A FR2757059B1 FR 2757059 B1 FR2757059 B1 FR 2757059B1 FR 9615287 A FR9615287 A FR 9615287A FR 9615287 A FR9615287 A FR 9615287A FR 2757059 B1 FR2757059 B1 FR 2757059B1
Authority
FR
France
Prior art keywords
new therapeutic
therapeutic application
pyrrole derivatives
pyrrole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9615287A
Other languages
English (en)
Other versions
FR2757059A1 (fr
Inventor
Anne Bousseau
Christine Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9615287A priority Critical patent/FR2757059B1/fr
Priority to AU54872/98A priority patent/AU5487298A/en
Priority to PCT/FR1997/002247 priority patent/WO1998025612A1/fr
Priority to MA24895A priority patent/MA24421A1/fr
Priority to TNTNSN97203A priority patent/TNSN97203A1/fr
Priority to ZA9711168A priority patent/ZA9711168B/xx
Publication of FR2757059A1 publication Critical patent/FR2757059A1/fr
Application granted granted Critical
Publication of FR2757059B1 publication Critical patent/FR2757059B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9615287A 1996-12-12 1996-12-12 Nouvelle application therapeutique des derives du pyrrole Expired - Fee Related FR2757059B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9615287A FR2757059B1 (fr) 1996-12-12 1996-12-12 Nouvelle application therapeutique des derives du pyrrole
AU54872/98A AU5487298A (en) 1996-12-12 1997-12-10 Novel therapeutic application of pyrrole derivatives
PCT/FR1997/002247 WO1998025612A1 (fr) 1996-12-12 1997-12-10 Nouvelle application therapeutique des derives du pyrrole
MA24895A MA24421A1 (fr) 1996-12-12 1997-12-10 Nouvelle application therapeutique de derives du pyrrole.
TNTNSN97203A TNSN97203A1 (fr) 1996-12-12 1997-12-10 Nouvelle application therapeutique des derives du pyrrole
ZA9711168A ZA9711168B (en) 1996-12-12 1997-12-11 New therapeutic application of pyrrole derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615287A FR2757059B1 (fr) 1996-12-12 1996-12-12 Nouvelle application therapeutique des derives du pyrrole

Publications (2)

Publication Number Publication Date
FR2757059A1 FR2757059A1 (fr) 1998-06-19
FR2757059B1 true FR2757059B1 (fr) 1999-01-29

Family

ID=9498603

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9615287A Expired - Fee Related FR2757059B1 (fr) 1996-12-12 1996-12-12 Nouvelle application therapeutique des derives du pyrrole

Country Status (6)

Country Link
AU (1) AU5487298A (fr)
FR (1) FR2757059B1 (fr)
MA (1) MA24421A1 (fr)
TN (1) TNSN97203A1 (fr)
WO (1) WO1998025612A1 (fr)
ZA (1) ZA9711168B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020506A1 (es) 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
ES2243579T3 (es) 2000-12-15 2005-12-01 Glaxo Group Ltd Derivados de pirazolopirideno.
ATE301653T1 (de) 2000-12-15 2005-08-15 Glaxo Group Ltd Pyrazolopyridine
WO2002072581A2 (fr) 2001-03-08 2002-09-19 Smithkline Beecham Corporation Composes therapeutiques
JP4237497B2 (ja) 2001-03-30 2009-03-11 スミスクライン ビーチャム コーポレーション ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
US7141569B2 (en) 2001-04-10 2006-11-28 Smithkline Beecham Corporation Antiviral pyrazolopyridine compounds
JP2004527560A (ja) 2001-04-27 2004-09-09 スミスクライン ビーチャム コーポレーション ピラゾロ［１，５−α］ピリジン誘導体
BR0210464A (pt) 2001-06-21 2004-07-20 Smithkline Beecham Corp Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
EP1432712B1 (fr) 2001-10-05 2006-05-17 SmithKline Beecham Corporation Derives imidazo-pyridine destines au traitement d'infection virale herpetique
ES2292839T3 (es) 2001-12-11 2008-03-16 Smithkline Beecham Corporation Derivados de pirazolo-piridina como agentes contra el herpes.
AU2003275266A1 (en) 2002-10-03 2004-05-04 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridine derivatives
GB0816759D0 (en) * 2008-09-12 2008-10-22 Selcia Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2557111B1 (fr) * 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
DE4129779A1 (de) * 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
ZA9711168B (en) 1998-06-15
WO1998025612A1 (fr) 1998-06-18
AU5487298A (en) 1998-07-03
FR2757059A1 (fr) 1998-06-19
TNSN97203A1 (fr) 2005-03-15
MA24421A1 (fr) 1998-07-01

Similar Documents

Publication Publication Date Title
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
PT944631E (pt) Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares
EE04190B1 (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks
PT907364E (pt) Composicao farmaceutica de libertacao sustida
PL331047A1 (en) Novel amidinic derivatives and their application as inhibitors of thrombosin
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
BR9508377A (pt) Derivados de acila anti-helicobacter de azolonas
MA23815A1 (fr) Derives de n-(3-benzofuranyl)-uree
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
DE69606165D1 (de) Bizyclische isothioharnstoff-derivate mit therapeutischer wirkung
FI973124A (fi) D-vitamiinijohdannaisten dermatologinen käyttö
IT1283489B1 (it) Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
FR2735476B1 (fr) Nouvelle application de derives du pyrrole
DE19581497T1 (de) Neue Derivate des Tetramethylcyclopropans
FR2755013B1 (fr) Nouvelle application therapeutique des antagonistes de la substance p
FR2687574B1 (fr) Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.
DE19648723B4 (de) 4-Aminophenol-Derivate
IS4554A (is) Lyfjafræðileg notkun ákveðinna sýstín afleiða
FR2691359B1 (fr) Nouvelle application therapeutique du malate de 1-citrulline.
NO962385L (no) Terapeutiske amider
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina

Legal Events

Date Code Title Description
ST Notification of lapse